Catherine Jacobson - 18 Feb 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 15:10:13 UTC
Previous filing
18 May 2021
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +734 +100% 1,468 18 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -734 -50% $0.000000 734 18 Feb 2022 Common Stock 734 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On February 21, 2020, the reporting person was granted 2,202 restricted stock units that vest in three substantially equal annual installments.